ASO Author Reflections: Stage-Specific Tumor Residual Thresholds Following Preoperative Therapies in Hepatocellular Carcinoma: Prognostic Implications and Tailored Management Strategies.

Uložené v:
Podrobná bibliografia
Názov: ASO Author Reflections: Stage-Specific Tumor Residual Thresholds Following Preoperative Therapies in Hepatocellular Carcinoma: Prognostic Implications and Tailored Management Strategies.
Autori: Xu H; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China., Zhang H; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China., Liu Y; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.; Department of General Surgery, West China Second Hospital, Sichuan University, Chengdu, China., Wu H; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China., Li B; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China., Chen K; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China., Wei Y; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. weiyonggang@wchscu.edu.cn.
Zdroj: Annals of surgical oncology [Ann Surg Oncol] 2025 Aug; Vol. 32 (8), pp. 5726-5727. Date of Electronic Publication: 2025 May 27.
Spôsob vydávania: Journal Article
Jazyk: English
Informácie o časopise: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: In Process; MEDLINE
Imprint Name(s): Publication: 2005- : New York, NY : Springer
Original Publication: New York, NY : Raven Press, c1994-
Abstrakt: Competing Interests: Disclosure: Hongwei Xu, Haili Zhang, Yani Liu, Haojun Wu, Bo Li, Kefei Chen, and Yonggang Wei have no conflicts of interest or disclaimers to declare that may be relevant to the contents of this study.
References: Wu J-Y, Zhang Z-B, Zhou J-Y, et al. Outcomes of salvage surgery for initially unresectable hepatocellular carcinoma converted by transcatheter arterial chemoembolization combined with lenvatinib plus anti-PD-1 antibodies: a multicenter retrospective study. Liver Cancer. 2022;12(3):229–37. (PMID: 10.1159/0005283563776706710521320)
Zeng Z-X, Wu J-Y, Wu J-Y, et al. Prognostic value of pathological response for patients with unresectable hepatocellular carcinoma undergoing conversion surgery. Liver Cancer. 2024;13(5):498–508. (PMID: 10.1159/0005363763943527211493390)
D’Alessio A, Stefanini B, Blanter J, et al. Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis. Lancet Oncol. 2024;25(11):1465–75. (PMID: 10.1016/S1470-2045(24)00457-13943780412040480)
Xu H, Zhang H, Liu Y, et al. Prognostic impact of pathological response in patients with hepatocellular carcinoma following preoperative treatments. Ann Surg Oncol. 2025. https://doi.org/10.1245/s10434-025-17453-z . (PMID: 10.1245/s10434-025-17453-z4058707012129847)
Entry Date(s): Date Created: 20250527 Latest Revision: 20250704
Update Code: 20250704
DOI: 10.1245/s10434-025-17537-w
PMID: 40425910
Databáza: MEDLINE
Popis
Abstrakt:Competing Interests: Disclosure: Hongwei Xu, Haili Zhang, Yani Liu, Haojun Wu, Bo Li, Kefei Chen, and Yonggang Wei have no conflicts of interest or disclaimers to declare that may be relevant to the contents of this study.
ISSN:1534-4681
DOI:10.1245/s10434-025-17537-w